Skip to main content
Premium Trial:

Request an Annual Quote

Pierre Chretien, Michael Berens, Robert Penny, Michael Bittner, Michael Rodgers, Thomas Klopack, Joseph Limber, Ed Hurwitz

Premium

Pierre Chretien of Montreal was named director of Canada marketing and business development for the company Pure Protein. Previously, Chretien was chief technical officer for SignalGene.

 

Michael Berens, a researcher at Arizona’s Translational Genomics Research Institute, has become CEO of the International Genomics Consortium, according to an IGC announcement. Berens, a former researcher at the Barrow Neurological Institute, will keep his position as senior investigator at the Translational Genomics Research Institute in order to be able to pursue federally funded research. Further, the Phoenix, Ariz.-based consortium named Robert Penny as chief medical officer, Michael Bittner as chief research officer, and Michael Rodgers as chief financial officer. In addition, Max Poll, president and CEO at Scottsdale Healthcare, was elected to the IGC’s board.

 

Aclara Biosciences has appointed Thomas Klopack as CEO. Klopack was COO of Aurora Biosciences from 1998 until 2002. He fills an opening created when CEO Joseph Limber left last December, and Ed Hurwitz, a board member who was appointed interim CEO at the time, then stepped down Feb. 21. Klopack holds an MBA from Harvard Business School and a BS in engineering from Carnegie-Mellon University.

 

The Scan

Fertility Fraud Found

Consumer genetic testing has uncovered cases of fertility fraud that are leading to lawsuits, according to USA Today.

Ties Between Vigorous Exercise, ALS in Genetically At-Risk People

Regular strenuous exercise could contribute to motor neuron disease development among those already at genetic risk, Sky News reports.

Test Warning

The Guardian writes that the US regulators have warned against using a rapid COVID-19 test that is a key part of mass testing in the UK.

Science Papers Examine Feedback Mechanism Affecting Xist, Continuous Health Monitoring for Precision Medicine

In Science this week: analysis of cis confinement of the X-inactive specific transcript, and more.